Abstract
To investigate the efficacy, safety and feasibility of AngioJet Rheolytic Thrombectomy (ART) in the treatment of acute pulmonary embolism (APE). Twelve patients with intermediate- or high-risk APE received ART and were followed up for 6 to 32 months. The technical success rate, clinical success rate, mortality, complication, and ancillary and laboratory tests before and after operation were analyzed retrospectively. The technical and clinical success rate of ART were both 91.67% (11/12). Except for the patient who died of heart failure during the operation, the rest of patients had no serious complications. After operation, PaO2 increased while HGB and Tn decreased (P<0.05). All patients were free of recurrence of APE after 6 to 32 months of follow-up. Pulmonary artery thrombosis significantly reduced or disappeared. ART is an effective treatment for intermediate- and high-risk APE. It quickly clears the main pulmonary artery thrombus, relieves pulmonary hypertension and improve the long-term prognosis of patients.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
